Hologic, Inc. (HOLX) saw its share price trade relatively negative in the recent trading session. The share price was last updated to $40.51 with a loss of -0.03 points or -0.06%. The net money flow was $7.85 million and the up/down ratio was 1.85. Approximately $17.12 million was the inflow in upticks and $9.28 million was the outflow in downticks. On a weekly measure, the shares have seen a price change of -0.18%.The shares witnessed a block transaction with a net money flow of $7.74 million. The total money in uptick was $8.75 million and in downtick was $1.02 million with the up/down ratio reaching 8.59.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.
Shares of Hologic, Inc. rose by 1.44% in the last five trading days and 1.82% for the last 4 weeks. Hologic, Inc. is up 13.44% in the last 3-month period. Year-to-Date the stock performance stands at 1.82%. Hologic, Inc. (NASDAQ:HOLX) rose 0.79% or 0.32 points on Wednesday and made its way into the gainers of the day. After trading began at $40.67 the stock was seen hitting $41.24 as a peak level and $40.42 as the lowest level. The stock ended up at $40.85. The daily volume was measured at 4,582,823 shares. The 52-week high of the share price is $41.24 and the 52-week low is $31.84. The company has a market cap of $11,407 million.
Company has reported several Insider transactions to the SEC, on Jan 5, 2017, Elaine Ullian (director) sold 9,351 shares at 40.00 per share price.On Jan 5, 2017, Nancy Leaming (director) sold 8,737 shares at 40.06 per share price.On Dec 16, 2016, Sally Crawford (director) sold 17,626 shares at 41.00 per share price.
Hologic Last issued its quarterly earnings results on Feb 1, 2017. The company reported $0.52 EPS for the quarter, beating the analyst consensus estimate by $ 0.01. Analyst had a consensus of $0.51. The company had revenue of $734.40 million for the quarter, compared to analysts expectations of $724.47 million. The companys revenue was up 5.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.46 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Hologic was Initiated by Deutsche Bank on Jan 18, 2017 to Buy, Price Target of the shares are set at $48.Hologic was Upgraded by Piper Jaffray to Overweight on Jan 4, 2017.
Hologic Inc. is a leading supplier of high quality, innovative and clinically valuable diagnostic systems and tests. The company develops, manufactures and markets X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment — a key element of womens health care. The systems are used by more leading medical schools, universities and osteoporosis opinion leaders than any other bone densitometer.